Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer

Journal of Surgical Oncology

Volumn 82, Issue 4, 2003, Pages 256-260

  Prenzel, Klaus L ^a   Mönig, Stefan P ^a   Sinning, Jan M ^a   Baldus, Stefan E ^a   Gutschow, Christian A ^a   Grass, Guido ^a   Schneider, Paul M ^a   Hölscher, Arnulf H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Non small cell lung cancer; Skip metastasis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MEDIASTINUM LYMPH NODE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SKIP METASTASIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0037379852     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10219     Document Type: Article

References (24)

1. Martini N, Flehniger BJ, Zaman MB, et al.: Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983;198:386-397.
2. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al.: Survival and prognostic factors in resected N2 non-small-cell lung cancer: A study of 140 cases. Ann Thorac Surg 1997;63:1441-1450.
3. Detterbeck FC, Jones DR: Surgical treatment of IIIA (N2) non-small-cell lung cancer. In: Detterbeck FC, Rivera MP, Socinski MA, Rosenman G (eds): Diagnosis and treatment of lung cancer. Philadelphia: WB Saunders. 2001; 244-256.
4. Okada M, Tsubota N, Yoshimura M, et al.: Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival? J Thorac Cardiovasc Surg 1999;188:270-275.
5. Nakanishi R, Osaki T, Nakanishi K, et al.: Treatment strategy for patients with surgically discovered N2-stage non-small cell lung cancer. Ann Thorac Surg 1997;64:342-348.
6. Miller DL, McManus KG, Allen MS, et al.: Results of surgical resections in patients with N2 non-small cell lung cancer. Ann Thorac Surg 1994;57:1095-1101.
7. Watanabe Y, Shimizu J, Oda M, et al.: Improved survival in left non-small cell N2 lung cancer after more extensive operative procedure. Thorac Cardiovasc Surg 1991;39:89-93.
8. Ishida T, Yano T, Maeda K, et al.: Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorc Surg 1990;50:708-713.
9. Tateishi M, Fukuyama Y, Hamatake M, et al.: Skip mediastinal lymph node metastasis in non-small cell lung cancer. J Surg Oncol 1994;57:139-142.
10. Mountain CF: Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
11. Takizawa T, Terashima M, Koike T, et al.: Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg 1997;113:248-252.
12. Naruke T, Goya T, Tsuchiya R, et al.: The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 1988;46:603-610.
13. Bonner JA, Garces YI, Sawyer TE, et al.: Frequency of non-contiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma. Cancer 1999;86:1159-1164.
14. Riquet M, Hidden G, Debesse B: Direct lymphatic drainage of lung segments to mediastinal nodes. J Thorac Cardiovasc Surg 1989;97:623-632.
15. Asamura H, Nakayama H, Kondo H, et al.: Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small cell lung carcinomas: Are these carcinomas candidates for videoassisted lobectomy? J Thorac Cardiovasc Surg 1996;111: 1125-1134.
16. Tsubota N, Yoshimura M: Skip metastasis and hidden N2 disease in lung cancer: How successful is mediastinal dissection? Jpn J Surg 1996;26:169-172.
17. Yoshino I, Yokoyama H, Yano T, et al.: Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg 1996;62:1021-1025.
18. Passlik B, Izbicki JR, Kubuschok B, et al.: Detection of disseminated lung cancer cells in lymph nodes impact on staging and prognosis. Ann Thorac Surg 1996;62:352-355.
19. Kubuschok B, Passlick B, Izbicki JR, et al.: Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 1999;17: 19-24.
20. Maruyama R, Sugio K, Mitsudomi T, et al.: Relationship between early recurrence and micrometastasis in lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 1997;114:535-543.
21. Fukuse T, Hirata T, Naiki N, et al.: Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases. Ann Surg 2000;232: 112-118.
22. Goldstraw P, Mannam GC, Kaplan DK, et al.: Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994; 107:19-28.
23. Lau CL, D'Amico TA, Harpole DH: Clinical and molecular prognostic factors and models for non-small cell cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD (eds): Lung cancer. Philadelphia: Lippincott Williams & Wilkins. 2000; 602-611.
24. Long L, Rubin R, Brodt P: Enhanced invasion and liver colonization by lung carcinoma cells overexpression the type I insulin-like growth factor receptor. Exp Cell Res 1998;238:116-121.